Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Mouse Clusterin / ApoJ Antibody | Login | Anti-Mouse Clusterin / ApoJ Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-CG beta (core) Antibody | Login | Anti-CG beta (core) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8 Antibody, Biotinylated | Login | Anti-Mouse CD8 Antibody, Biotinylated | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD8 Antibody, FITC | Login | Anti-Mouse CD8 Antibody, FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD8 Antibody, Biotinylated | Login | Anti-CD8 Antibody, Biotinylated | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD8 Antibody, FITC | Login | Anti-CD8 Antibody, FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD45 Antibody | Login | Anti-CD45 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD45 Antibody, FITC | Login | Anti-CD45 Antibody, FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD44 Antibody | Login | Anti-CD44 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD44 Antibody | Login | Anti-Mouse CD44 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD44 Antibody, FITC | Login | Anti-CD44 Antibody, FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD44 Antibody, FITC | Login | Anti-Mouse CD44 Antibody, FITC | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD20 / MS4A1 (C Terminus) Antibody | Login | Anti-CD20 / MS4A1 (C Terminus) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-beta-Lipotropin Antibody | Login | Anti-beta-Lipotropin Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse B220 (CD45R) Antibody | Login | Anti-Mouse B220 (CD45R) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Notch 3 Antibody | Login | Anti-Notch 3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-SEPT2 Antibody | Login | Anti-SEPT2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-SEPT6 Antibody | Login | Anti-SEPT6 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CTLA-4 / CD152 Antibody | Login | Anti-Mouse CTLA-4 / CD152 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD20 Antibody | Login | Anti-CD20 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-HSP70 Interacting Protein Antibody | Login | Anti-HSP70 Interacting Protein Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-HSP70 Interacting Protein Antibody | Login | Anti-HSP70 Interacting Protein Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Herstatin Antibody | Login | Anti-Herstatin Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Herstatin Antibody | Login | Anti-Herstatin Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Herstatin Antibody | Login | Anti-Herstatin Antibody | ||||||||||||||||
|
||||||||||||||||||


